These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 34715867)

  • 21. 'Mito-Bomb': a novel mitochondria-targeting nanosystem for ferroptosis-boosted sonodynamic antitumor therapy.
    Wang J; Zhao Z; Liu Y; Cao X; Li F; Ran H; Cao Y; Wu C
    Drug Deliv; 2022 Dec; 29(1):3111-3122. PubMed ID: 36131565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coadministration of iRGD peptide with ROS-sensitive nanoparticles co-delivering siFGL1 and siPD-L1 enhanced tumor immunotherapy.
    Wan WJ; Huang G; Wang Y; Tang Y; Li H; Jia CH; Liu Y; You BG; Zhang XN
    Acta Biomater; 2021 Dec; 136():473-484. PubMed ID: 34571271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression.
    Pierini S; Mishra A; Perales-Linares R; Uribe-Herranz M; Beghi S; Giglio A; Pustylnikov S; Costabile F; Rafail S; Amici A; Facciponte JG; Koumenis C; Facciabene A
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33563772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An ultrasound-activated nanoplatform remodels tumor microenvironment through diverse cell death induction for improved immunotherapy.
    Ma J; Yuan H; Zhang J; Sun X; Yi L; Li W; Li Z; Fu C; Zheng L; Xu X; Wang X; Wang F; Yin D; Yuan J; Xu C; Li Z; Peng X; Wang J
    J Control Release; 2024 Jun; 370():501-515. PubMed ID: 38703950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cavitation assisted endoplasmic reticulum targeted sonodynamic droplets to enhanced anti-PD-L1 immunotherapy in pancreatic cancer.
    Chen J; Feng L; Jin P; Shen J; Lu J; Song Y; Wang G; Chen Q; Huang D; Zhang Y; Zhang C; Xu Y; Huang P
    J Nanobiotechnology; 2022 Jun; 20(1):283. PubMed ID: 35710424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Redox-Triggered Autophagy-Induced Nanoplatform with PD-L1 Inhibition for Enhancing Combined Chemo-Immunotherapy.
    Li M; Zhao D; Yan J; Fu X; Li F; Liu G; Fan Y; Liang Y; Zhang X
    ACS Nano; 2024 May; 18(20):12870-12884. PubMed ID: 38727063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer.
    Si Y; Yue J; Liu Z; Li M; Du F; Wang X; Dai Z; Hu N; Ju J; Gao S; Wang X; Yuan P
    Int J Nanomedicine; 2021; 16():1913-1926. PubMed ID: 33707946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy.
    Song S; Shim MK; Yang S; Lee J; Yun WS; Cho H; Moon Y; Min JY; Han EH; Yoon HY; Kim K
    Bioact Mater; 2023 Oct; 28():358-375. PubMed ID: 37334068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic therapy synergizes with PD-L1 checkpoint blockade for immunotherapy of CRC by multifunctional nanoparticles.
    Yuan Z; Fan G; Wu H; Liu C; Zhan Y; Qiu Y; Shou C; Gao F; Zhang J; Yin P; Xu K
    Mol Ther; 2021 Oct; 29(10):2931-2948. PubMed ID: 34023507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models.
    Karoon Kiani F; Izadi S; Ansari Dezfouli E; Ebrahimi F; Mohammadi M; Chalajour H; Mortazavi Bulus M; Nasr Esfahani M; Karpisheh V; Mahmoud Salehi Khesht A; Abbaszadeh-Goudarzi K; Soleimani A; Gholizadeh Navashenaq J; Ahmadi M; Hassannia H; Hojjat-Farsangi M; Shahmohammadi Farid S; Hashemi V; Jadidi-Niaragh F
    Life Sci; 2022 Jan; 288():120166. PubMed ID: 34813798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide-Appended Nanosonosensitizers Targeting Tumor Glycolysis for Synergistic Sonodynamic-Immunometabolic Therapy of Spinal-Metastasized Tumors.
    Chen Z; Chen L; Ma Y; Liu Y; Zhang Q; Qin H; Chen Y; Tian B; Dong J
    Adv Mater; 2023 Oct; 35(42):e2304246. PubMed ID: 37460111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor redox microenvironment modulating composite hydrogels for enhanced sonodynamic therapy of colorectal cancer.
    Chen W; Zhang C; Chen D; Li Y; Wu S; Xu C; Su L; Zhang Q
    J Mater Chem B; 2022 Mar; 10(12):1960-1968. PubMed ID: 35195150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyroptosis Induction with Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with PD-L1 Blockade Boosts Efficacy against Liver Cancer.
    Zhang N; Zeng W; Xu Y; Li R; Wang M; Liu Y; Qu S; Ferrara KW; Dai Z
    Adv Healthc Mater; 2024 Mar; 13(7):e2302606. PubMed ID: 37987462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondria-Targeted and Ultrasound-Activated Nanodroplets for Enhanced Deep-Penetration Sonodynamic Cancer Therapy.
    Zhang L; Yi H; Song J; Huang J; Yang K; Tan B; Wang D; Yang N; Wang Z; Li X
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):9355-9366. PubMed ID: 30734551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomaterials-based precision sonodynamic therapy enhancing immune checkpoint blockade: A promising strategy targeting solid tumor.
    Dai X; Du Y; Li Y; Yan F
    Mater Today Bio; 2023 Dec; 23():100796. PubMed ID: 37766898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxorubicin and siRNA-PD-L1 co-delivery with T7 modified ROS-sensitive nanoparticles for tumor chemoimmunotherapy.
    Wan WJ; Qu CX; Zhou YJ; Zhang L; Chen MT; Liu Y; You BG; Li F; Wang DD; Zhang XN
    Int J Pharm; 2019 Jul; 566():731-744. PubMed ID: 31212055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoenabled Tumor Energy Metabolism Disorder via Sonodynamic Therapy for Multidrug Resistance Reversal and Metastasis Inhibition.
    Guo X; Tu P; Zhu L; Cheng C; Jiang W; Du C; Wang X; Qiu X; Luo Y; Wan L; Tang R; Ran H; Wang Z; Ren J
    ACS Appl Mater Interfaces; 2023 Jan; 15(1):309-326. PubMed ID: 36576435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy.
    Luo J; Wang X; Shi Z; Zeng Y; He L; Cao J; Sun Y; Zhang T; Huang P
    J Nanobiotechnology; 2022 May; 20(1):228. PubMed ID: 35568916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy.
    Lee Y; Song S; Yang S; Kim J; Moon Y; Shim N; Yoon HY; Kim S; Shim MK; Kim K
    Acta Pharm Sin B; 2024 Mar; 14(3):1428-1440. PubMed ID: 38487005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.
    Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE
    J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.